These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 21958527)
1. Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy. Bagley RG; Rouleau C; Weber W; Mehraein K; Smale R; Curiel M; Callahan M; Roy A; Boutin P; St Martin T; Nacht M; Teicher BA Microvasc Res; 2011 Nov; 82(3):253-62. PubMed ID: 21958527 [TBL] [Abstract][Full Text] [Related]
2. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246 [TBL] [Abstract][Full Text] [Related]
3. Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression. Rmali KA; Watkins G; Harrison G; Parr C; Puntis MC; Jiang WG Eur J Surg Oncol; 2004 Nov; 30(9):948-53. PubMed ID: 15498639 [TBL] [Abstract][Full Text] [Related]
4. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers. Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723 [TBL] [Abstract][Full Text] [Related]
5. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Bagley RG; Walter-Yohrling J; Cao X; Weber W; Simons B; Cook BP; Chartrand SD; Wang C; Madden SL; Teicher BA Cancer Res; 2003 Sep; 63(18):5866-73. PubMed ID: 14522911 [TBL] [Abstract][Full Text] [Related]
6. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677 [TBL] [Abstract][Full Text] [Related]
7. Isolation of human antibodies to tumor-associated endothelial cell markers by in vitro human endothelial cell selection with phage display libraries. Mutuberria R; Satijn S; Huijbers A; Van Der Linden E; Lichtenbeld H; Chames P; Arends JW; Hoogenboom HR J Immunol Methods; 2004 Apr; 287(1-2):31-47. PubMed ID: 15099754 [TBL] [Abstract][Full Text] [Related]
8. Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues. Selman L; Skjodt K; Nielsen O; Floridon C; Holmskov U; Hansen S Mol Immunol; 2008 Jun; 45(11):3278-88. PubMed ID: 18423602 [TBL] [Abstract][Full Text] [Related]
9. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
10. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers. Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938 [TBL] [Abstract][Full Text] [Related]
11. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383 [TBL] [Abstract][Full Text] [Related]
12. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Bischof M; Abdollahi A; Gong P; Stoffregen C; Lipson KE; Debus JU; Weber KJ; Huber PE Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1220-32. PubMed ID: 15519795 [TBL] [Abstract][Full Text] [Related]
14. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. Macabeo-Ong M; Ginzinger DG; Dekker N; McMillan A; Regezi JA; Wong DT; Jordan RC Mod Pathol; 2002 Sep; 15(9):979-87. PubMed ID: 12218216 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model. Li YY; Qian GS; Huang GJ; Chen F; Qian P; Yu SC; Wang CZ; Li Q; Wang JC; Wu GM Cancer J; 2006; 12(2):136-46. PubMed ID: 16630405 [TBL] [Abstract][Full Text] [Related]
16. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869 [TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor. Morais C; Gobe G; Johnson DW; Healy H Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells. Pasquier E; Honore S; Pourroy B; Jordan MA; Lehmann M; Briand C; Braguer D Cancer Res; 2005 Mar; 65(6):2433-40. PubMed ID: 15781659 [TBL] [Abstract][Full Text] [Related]
19. Expression of CD44v3 protein in human endothelial cells in vitro and in tumoral microvessels in vivo. Forster-Horváth C; Mészáros L; Rásó E; Döme B; Ladányi A; Morini M; Albini A; Tímár J Microvasc Res; 2004 Sep; 68(2):110-8. PubMed ID: 15313120 [TBL] [Abstract][Full Text] [Related]
20. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Guo K; Li J; Wang H; Osato M; Tang JP; Quah SY; Gan BQ; Zeng Q Cancer Res; 2006 Oct; 66(19):9625-35. PubMed ID: 17018620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]